CIP
RETA

Chartwell Investment Partners’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History

Chartwell Investment Partners’s Portfolio RETA Stock Details RETA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-4,925
Closed -$768K – 436
2020
Q2 		$768K Buy
+4,925
New +$768K 0.03% 352